ARA-290

Description

ARA-290 is a next-generation variant of erythropoietin developed to harness powerful cellular repair and anti-inflammatory properties—without triggering the red blood cell–producing effects associated with conventional erythropoietin. Designed to work through paracrine signaling and the body’s innate repair receptors, ARA-290 activates natural healing pathways that support cellular recovery, metabolic balance, and tissue resilience.

In research settings, ARA-290 has demonstrated impressive potential across multiple areas of health and performance. Studies suggest it can help improve blood sugar management by lowering HbA1c levels, making it of interest for metabolic support and long-term wellness strategies. In addition, it has been associated with healthier cholesterol profiles, helping promote cardiovascular efficiency and metabolic health.

Beyond its metabolic benefits, ARA-290 has also shown strong promise in the area of nerve support and recovery. Its ability to modulate neuropathic pain has made it a standout candidate in research focused on nerve function, comfort, and regeneration. At the same time, its role in stimulating wound repair highlights its potential to support faster recovery and enhanced tissue healing.

By targeting the body’s built-in repair systems at the cellular level, ARA-290 represents a new frontier in regenerative science—supporting inflammation control, metabolic health, nerve function, and healing in one advanced formulation.

Comes in 16mg vial

Provided as lyophilized powder intended strictly for experimental and research applications.